(0) Both deeply experienced in working with advanced life sciences technology, David Bennett joins as VP Commercial Operations and Sandra Bläser as VP of Customer Success, to satisfy strong demand for Eagle Genomics' microbiome discovery platform as global brands strive to create sustainable next-gen products CAMBRIDGE, England, May 26, 2021 /PRNewswire/ -- Eagle Genomics, a pioneer in applying network science to biology, has announced two new senior appointments to its global team, as market momentum around microbiome-based product innovation continues to accelerate. David Bennett, whose 40-year career spans roles at Unilever, Documentum, Veeva Systems, SeeBeyond and Zinc Ahead, has joined Eagle Genomics as VP of Commercial Operations. He brings comprehensive knowledge of next-generation IT combined with a deep first-hand understanding of R&D within global life sciences and household brands.